Jun Fei Feng

Director of Finance/CFO at Beijing Shenogen Pharma Group Ltd.

41 year

Consumer Services

Electronic Technology

Health Technology

Profile

Jun Fei Feng is currently the CFO, Board Secretary & Deputy GM at Beijing Shenogen Pharma Group Ltd.
He previously worked as a Secretary at Beijing Hanbang Technology Corp.
Mr. Feng graduated from Central University of Finance & Economics with a graduate degree in 2008 and from Northwest University of Politics & Law with an undergraduate degree in 2005.

Jun Fei Feng active positions

Companies	Position	Start
Beijing Shenogen Pharma Group Ltd. Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China.	Director of Finance/CFO	31/08/2019

All active positions of Jun Fei Feng

Former positions of Jun Fei Feng

Companies	Position	End
BEIJING HANBANG TECHNOLOGY CORP.	Corporate Secretary	-

See the detail of Jun Fei Feng's experience

Training of Jun Fei Feng

Northwest University of Politics & Law	Undergraduate Degree
Central University of Finance & Economics	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jun Fei Feng's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BEIJING HANBANG TECHNOLOGY CORP.	Electronic Technology

Private companies	1
Beijing Shenogen Pharma Group Ltd. Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China.	Health Technology